Related references
Note: Only part of the references are listed.Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Vanessa Andres-Guerrero et al.
ADVANCES IN THERAPY (2017)
Aflibercept for the treatment of neovascular glaucoma
Jeffrey R. SooHoo et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)
The link between intravitreal antivascular endothelial growth factor injections and glaucoma
Jeffrey R. SooHoo et al.
CURRENT OPINION IN OPHTHALMOLOGY (2014)
Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis
Shunji Nakatake et al.
BMC OPHTHALMOLOGY (2014)
Diabetic macular edema: new concepts in patho-physiology and treatment
Xinyuan Zhang et al.
CELL AND BIOSCIENCE (2014)
Human Ciliary Epithelium as a Source of Synthesis and Secretion of Vascular Endothelial Growth Factor in Neovascular Glaucoma
Kakarla V. Chalam et al.
JAMA OPHTHALMOLOGY (2014)
Novel Insight into the Inflammatory and Cellular Responses Following Experimental Glaucoma Surgery: A Roadmap for Inhibiting Fibrosis
L. -F. Seet et al.
CURRENT MOLECULAR MEDICINE (2013)
Levels of Erythropoietin and Vascular Endothelial Growth Factor in Surgery-Required Advanced Neovascular Glaucoma Eyes Before and After Intravitreal Injection of Bevacizumab
Minwen Zhou et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Vascular Endothelial Growth Factor in Anterior Chamber Liquid Patients with Diabetic Retinopathy, Cataract and Neovascular Glaucoma
Anatoly Kuzmin et al.
OPHTHALMOLOGY AND THERAPY (2013)
Level of Vascular Endothelial Growth Factor in Tenon Tissue and Results of Glaucoma Surgery
Hae-Young Lopilly Park et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab
Sung Chul Park et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Bleb Morphology and Vascularity After Trabeculectomy With Intravitreal Ranibizumab: A Pilot Study
Malik Y. Kahook
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients
Yosuke Sugimoto et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Trabeculectomy with Mitomycin C for Neovascular Glaucoma: Prognostic Factors for Surgical Failure
Yuji Takihara et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Level of Vascular Endothelial Growth Factor in Aqueous Humor and Surgical Results of Ahmed Glaucoma Valve Implantation in Patients With Neovascular Glaucoma
Yong Guk Kim et al.
JOURNAL OF GLAUCOMA (2009)
Bevacizumab (Avastin) for the Treatment of Ocular Disease
Jonathan B. Gunther et al.
SURVEY OF OPHTHALMOLOGY (2009)
Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma
Alyon Wasik et al.
OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION (2009)
Neovascular Glaucoma: Etiology, Diagnosis and Prognosis
Tarek A. Shazly et al.
SEMINARS IN OPHTHALMOLOGY (2009)
Needle Revision of Filtering Blebs
Robert M. Feldman et al.
JOURNAL OF GLAUCOMA (2008)
Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma
Milko E. Iliev et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Regression of neovascular iris vessels by intravitreal injection of bevacizumab
John O. Mason et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells
JW Sall et al.
EXPERIMENTAL EYE RESEARCH (2004)
Morphologic classification of filtering Blebs after glaucoma filtration surgery: The Indiana bleb appearance grading scale
LB Cantor et al.
JOURNAL OF GLAUCOMA (2003)
Share Paper
